In this article we want to address the topic of Pimethixene in depth, analyzing its implications from different perspectives and offering a complete overview of the issue. Pimethixene is a topic of utmost importance today, as it has a significant impact on various aspects of society. Throughout these pages, we will explore its origin, evolution, implications and possible solutions, with the aim of providing the reader with a broad and detailed overview of Pimethixene. Through a comprehensive and rigorous approach, we hope to contribute to the understanding and reflection on this topic that is so relevant today.
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral, nasal |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.005.675 |
| Chemical and physical data | |
| Formula | C19H19NS |
| Molar mass | 293.43 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Pimethixene is an antihistamine and anticholinergic of the thioxanthene chemical class originally developed to treat hyperactivity, anxiety, sleep disorders, and allergy. It is also used for anesthesia and as a bronchodilator (to dilate the bronchi and bronchioles for more airflow).
In combination with pholcodine, it was sold in France by Laboratoires Salvoxyl in the 1970s as the antitussive Salvodex. Pimethixene alone is still available in Brazil under the trade name Muricalm.
See also
References
- ^ Chefneux A (July 1978). "". Revue Médicale de Liège. 33 (14): 500–3. PMID 674966.
- ^ Bailly, Christian (8 December 2020). "Salvodex® (9-(1-methyl, 4-piperylidenyl)thiaxanthene and pholcodine), from Laboratoires Salvoxyl (Orléans), 1971". Oncowitan. Retrieved 4 January 2022.
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |